Blue Biofuels (BIOF) 10-Q 13 Aug 21 2021 Q2 Quarterly report Financial data

Cover

Cover - shares	6 Months Ended
	Jun. 30, 2021	Aug. 12, 2021
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Jun. 30, 2021
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2021
Current Fiscal Year End Date	--12-31
Entity File Number	000-54942
Entity Registrant Name	BLUE BIOFUELS, INC.
Entity Central Index Key	0001549145
Entity Tax Identification Number	45-4944960
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	3710 Buckeye Street
Entity Address, Address Line Two	Suite 120
Entity Address, City or Town	Palm Beach Gardens
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	33410
City Area Code	888
Local Phone Number	607-3555
Entity Current Reporting Status	No
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		272,411,065

Consolidated Balance Sheets (Un

Consolidated Balance Sheets (Unaudited) - USD ($)	Jun. 30, 2021	Dec. 31, 2020
Current assets
Cash and cash equivalents	$ 1,863,097	$ 286,579
Prepaid expenses	78,415	45,324
TOTAL CURRENT ASSETS	1,941,512	331,903
Other assets
Property and equipment, net of accumulated depreciation and amortization of $250,051 and $231,739 at June 30, 2021 and December 31,2020, respectively	305,131	247,431
Security deposits	30,276	30,276
Right of Use Assets, net of accumulated amortization	105,364	144,876
Patents	152,520	138,016
TOTAL OTHER ASSETS	593,291	560,599
TOTAL ASSETS	2,534,803	892,502
Current liabilities
Accounts payable	22,879	90,965
Accounts payable - Related Party	76,670	76,670
Deferred wages and director’s fees - Related party	235,795	676,477
Lease Liability - Current	83,825	80,078
Convertible Debentures — Related Party		75,000
Interest Payable - Related Party	56,868	99,268
TOTAL CURRENT LIABILITIES	476,037	1,098,458
Long term liabilities
Right of Use Lease Liability, net of current portion	29,372	72,346
Paycheck Protection Program SBA loan		66,330
Chapter 11 Settlement	50,000	50,000
Notes Payable — Related Party	2,521,562	2,521,562
Notes Payable — Other	216,570	216,570
Convertible debenture, payable from future profits — Related Party		204,000
TOTAL LONG TERM LIABILITIES	2,817,504	3,130,808
TOTAL LIABILITIES	3,293,541	4,229,266
STOCKHOLDERS’ EQUITY (deficit)
Preferred stock; $0.001 par value; 10,000,000 shares authorized; zero shares issued and outstanding
Common stock; $0.001 par value; 1,000,000,000 shares authorized; 272,311,065 issued and outstanding at June 30, 2021, and 241,721,947 shares issued and outstanding at December 31, 2020.	272,311	241,722
Additional paid-in capital	46,750,163	43,103,607
Accumulated deficit	(47,781,212)	(46,682,093)
Total stockholders’ equity	(758,738)	(3,336,764)
TOTAL EQUITY (DEFICIT)	(758,738)	(3,336,764)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT	$ 2,534,804	$ 892,502

Consolidated Balance Sheets (_2

Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($)	Jun. 30, 2021	Dec. 31, 2020
Statement of Financial Position [Abstract]
Accumulated depreciation and amortization on property and equipment	$ 250,051	$ 231,739
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	1,000,000,000	1,000,000,000
Common stock, shares issued	272,311,065	241,721,947
Common stock, shares outstanding	272,311,065	241,721,947

Consolidated Statement of Opera

Consolidated Statement of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
Income Statement [Abstract]
Revenues
Operating expense:
General and administrative	293,372	678,106	599,649	878,140
Research & Development	249,786	492,117	514,860	582,733
Loss on disposal of assets			33,484
Total operating expenses	543,158	1,170,223	1,147,992	1,460,873
Loss from operations:	(543,158)	(1,170,223)	(1,147,992)	(1,460,873)
Other (income) expense:
Loan Forgiveness	(66,330)		(66,330)
Interest expense - related party	6,812	34,197	13,661	139,275
Interest expense - other	1,896	1,840	3,796	3,966
Total other (income) expense	(57,622)	36,037	(48,873)	143,241
Income (Loss) before provisions for income taxes	(485,535)	(1,206,260)	(1,099,119)	(1,604,114)
Provisions for income taxes
Net Income / (Loss):	$ (485,535)	$ (1,206,260)	$ (1,099,119)	$ (1,604,114)
Net income (loss) per share	$ (0.002)	$ (0.005)	$ (0.004)	$ (0.007)
Weighted average common shares outstanding
Basic	266,513,255	224,059,843	266,513,255	224,059,843

Consolidated Statements of Stoc

Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)	Common Stock [Member]	Preferred Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Dec. 31, 2019	$ 219,513		$ 40,949,645	$ (44,500,966)	$ (3,331,808)
Beginning balance, shares at Dec. 31, 2019	219,513,233
Issuance of common stock for services	$ 705		34,295		35,000
Issuance of common stock for services, shares	705,352
Issuance of common stock and warrants for cash through PPM	$ 9,025		538,355		547,380
Issuance of common stock and warrants for cash through PPM, shares	9,025,129
Issuance of vested options under the employee, director plan			847,574		847,574
Net Income (Loss)				(1,604,114)	(1,604,114)
Ending balance, value at Jun. 30, 2020	$ 229,243		42,369,869	(46,105,080)	(3,505,968)
Ending balance, shares at Jun. 30, 2020	229,243,714
Beginning balance, value at Dec. 31, 2020	$ 241,722		43,103,607	(46,682,093)	(3,336,764)
Beginning balance, shares at Dec. 31, 2020	241,721,947
Issuance of common stock for services	$ 223		46,707		$ 46,930
Issuance of common stock for services, shares	223,000				223,000
Issuance of warrants for services			72,090		$ 72,090
Warrants exercised	$ 13,455		1,289,362		$ 1,302,817
Warrants exercised, shares	13,455,009				13,455,009
Issuance of common stock and warrants for cash through PPM	$ 9,303		1,941,447		$ 1,950,750
Issuance of common stock and warrants for cash through PPM, shares	9,303,331				9,303,331
Issuance of common stock in exchange for debt	$ 7,080		271,920		$ 279,000
Issuance of common stock in exchange for debt, shares	7,080,000				7,080,000
Issuance of vested options under the employee, director plan			12,658		$ 12,658
Employee stock options exercised	$ 350		12,550		$ 12,900
Employee stock options exercised, shares	350,000				350,000
Cashless exercise of stock options	$ 178		(178)		$ 0
Cashless exercise of stock options, shares	177,778				177,778
Net Income (Loss)				(1,099,119)	$ (1,099,119)
Ending balance, value at Jun. 30, 2021	$ 272,311		$ 46,750,163	$ (47,781,212)	$ (758,738)
Ending balance, shares at Jun. 30, 2021	272,311,065

Consolidated Statements of St_2

Consolidated Statements of Stockholders' Equity (Unaudited) (Parenthetical) - shares	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Statement of Stockholders' Equity [Abstract]
Vested options issued under the employee director plan	210,000	10,300,000
Warrants issued for service	1,166,667

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Cash flows from operating activities
Net Income (Loss)	$ (1,099,119)	$ (1,604,114)
Reconciliation of net loss to net cash used in operating activities
Depreciation and amortization	63,001	59,271
Stock based compensation for services	46,930	35,000
Net Issuance of options and warrants for services	84,748	847,574
Loss on Disposal of assets	33,484
Changes in operating assets and liabilities
Prepaid expenses	(33,091)	63,618
Accrued interest - related party	(42,400)	139,275
Accounts payable and accrued liabilities	(508,768)	84,711
Forgiveness of PPP Loan	(66,330)
Right of use lease	(39,227)	(38,084)
Net cash used in operating activities	(1,560,772)	(412,748)
Cash flows from investing activities
Purchase of property and equipment	(114,673)	(134,718)
Security deposits
Patent Costs	(14,504)	(1,100)
Net cash from (used in) investing activities	(129,177)	(135,818)
Cash flows from financing activities
Proceeds from PPP Loan		66,330
Proceeds from exercise of warrants and options	1,315,717
Net proceeds from issuance of common stock	1,950,750	547,380
Net cash provided by financing activities	3,266,467	613,710
Net increase (decrease) in cash and cash equivalents	1,576,518	65,144
Cash and cash equivalent at beginning of the period	286,579	110,630
Cash and cash equivalent at end of the period	1,863,097	175,774
Cash paid during the period for
Interest
Taxes
Supplemental schedule of non-cash activities
Cashless conversion of warrants/options
Conversion of convertible debenture to common stock	$ 279,000

ORGANIZATION

ORGANIZATION	6 Months Ended
	Jun. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
ORGANIZATION	NOTE 1 – ORGANIZATION Blue Biofuels, Inc (the “Company”) is a technology company focused on emerging technologies in the renewable energy, biofuels, and new technologies sectors. In early 2018, our chief executive officer Ben Slager invented a new technology system it calls Cellulose-to-Sugar 2.0 or CTS 2.0, and a patent was granted in April 2021. Three additional patents pertaining to the technology have been filed in 2021. The 100% The new technology made it worthwhile to financially restructure the Company through Chapter 11. The Company voluntarily filed for Chapter 11 on October 22, 2018, in the U.S. Bankruptcy Court in the Southern District of Florida. The Company exited Chapter 11 on September 18, 2019, while keeping all classes, including shareholders, unimpaired. The bankruptcy case was closed on October 25, 2019. The Company’s focus is to commercialize its wholly owned CTS 2.0 technology. The Company is currently working with its 4 th th Plan of Operation The Company is now doing the engineering work to commercialize its 100% owned CTS 2.0 technology. The Company has a strategy to diversify its product portfolio to potentially include the following: 1) Producing and selling sugar or ethanol either direct or in combination with joint ventures, mergers, and/or acquisitions of existing businesses in the renewable energy space; 2) Producing and selling low-cost high purity lignin, or using that lignin to produce biodegradable bioplastics, or making biodegradable bioplastics products and selling them under our own brand. 3) Producing and selling other co-products like nanocellulose and specialty chemicals.

GOING CONCERN

GOING CONCERN	6 Months Ended
	Jun. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
GOING CONCERN	NOTE 2 – GOING CONCERN The accompanying consolidated financial statements have been prepared in conformity with generally accepted accounting principles, which contemplate continuation of the Company as a going concern, which assumes the Company will realize its assets and discharge its liabilities in the normal course of business. The Company has not generated any significant revenue since inception and has incurred losses since inception. As of June 30, 2021, the Company has a working capital surplus of $ 1,465,475 47,781,212 Management believes that the Company’s future success is dependent upon its ability to achieve profitable operations, generate cash from operating activities and obtain additional financing. There is no assurance that the Company will be able to generate sufficient cash from operations, sell additional shares of stock or borrow additional funds. The Company’s inability to obtain additional cash could have a material adverse effect on its financial position, results of operations, and its ability to continue in existence. These financial statements do not include any adjustments that might result from the outcome of this uncertainty. The Company intends to raise additional capital and continue engineering work and scaling up towards a full-scale commercial size CTS 2.0 modular unit. At that point, and to minimize dilution to shareholders, the Company will seek project-based financing to build (or acquire and retrofit) or joint venture with existing ethanol producers to produce cellulosic ethanol and lignin/bioplastics from its patented CTS 2.0 system. Once the first plant is profitable, the Company intends to grow with additional plants both in the United States and internationally. Currently, the US government gives a D3 RIN to incentivize the production of renewable fuels from cellulosic materials. The value of the D3 RIN fluctuates, but as of this filing, it is around $ 3.06 The Company believes that its CTS 2.0 process can produce ethanol profitably at the market price, and with the D3 RIN should generate substantial profits and cash flow in amounts sufficient to cover the Company’s operating expenses and debt service. Our business, results of operations, and financial condition may be adversely impacted by the COVID-19 pandemic The COVID-19 pandemic has negatively affected the U.S. and global economies, disrupted global supply chains, resulted in significant travel and transport restrictions, including mandated closures and orders to “shelter-in-place,” and created significant disruption of the financial markets. We are closely monitoring the impact of the COVID-19 pandemic on all aspects of our business, including how it will impact our customers, employees and supply chain. Given the critical nature of the products that we provide, our office and lab have remained open during the pandemic. The extent to which our operations may be impacted by the COVID-19 pandemic will depend largely on future developments, which are highly uncertain and cannot be accurately predicted. We may experience additional operating costs due to increased challenges with our workforce (including as a result of illness, absenteeism or government orders), access to supplies, capital, and fundamental support services (such as shipping and transportation). Even after the COVID-19 pandemic has subsided, we may experience materially adverse impacts to our business due to any resulting economic recession or depression. Furthermore, the impacts of a potential worsening of global economic conditions and the continued disruptions to and volatility in the financial markets remain unknown.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	6 Months Ended
	Jun. 30, 2021
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying consolidated financial statements of the Company were prepared in accordance with generally accepted accounting principles in the U.S. (“U.S. GAAP”) and include the assets, liabilities, revenues and expenses of the Company’s majority-owned subsidiaries over which the Company exercises control. Principles of Consolidation The accompanying consolidated financial statements include the accounts of the Company and its subsidiaries, after elimination of intercompany accounts and transactions. Investments in business entities in which the Company lacks control but has the ability to exercise significant influence over operating and financial policies are accounted for using the equity method. All material intercompany transactions and balances were eliminated in consolidation. Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the dates presented and reported amounts of revenues and expenses during the reporting periods presented. Significant estimates inherent in the preparation of the accompanying Consolidated Financial Statements include estimates of impairment assessment of identifiable intangible assets and valuation allowance for deferred tax assets. Estimates are based on past experience and other considerations reasonable under the circumstances. Actual results may differ from these estimates. Cash and Cash Equivalents All highly liquid investments with maturities of three months or less at the date of purchase are considered to be cash equivalents. Stock Compensation The Company recognizes the cost of all share-based payments under the relevant authoritative accounting guidance. Share-based payments include any remuneration paid by the Company in shares of the Company’s common stock or financial instruments that grant the recipient the right to acquire shares of the Company’s common stock. For share-based payments to employees, which consist only of awards made under the stock option plan described below, the Company accounts for the payments in accordance with the provisions of ASC Topic 718, “Stock Compensation” (formerly referred to as SFAS No. 123(R)). Share-based payments to consultants, service providers and other non-employees are accounted for in accordance with ASC Topic 718, ASC Topic 505, “Equity Payments to Non-Employees” or other applicable authoritative guidance. Stock-based Compensation Valuation Methodology Stock-based compensation resulting from the issuance of common stock is calculated by reference to the valuation of the stock on the date of issuance, the expense being recognized as the compensation is earned. Stock-based compensation expenses related to employee options and warrants granted to non-employees are recognized as the stock options and warrants are earned. The fair value of the stock options or warrants granted is estimated at the grant date, using the Black-Scholes option-pricing model, and the expense is recognized on a straight-line basis over the shorter of the period over which services are to be received or the life of the option or warrant. The grant date fair value of employee share options and similar instruments is estimated using the Black-Scholes option-pricing model on the basis of the fair value of the underlying common stock on the measurement date, adjusted for the unique characteristics of those equity instruments, using the assumptions noted in the table below. The fair value of the common stock is determined by the then-prevailing closing market price. Expected volatility was based on the historical volatility of the Company’s closing day market price per share. The expected term of options and warrants was based upon the life of the option, and the risk-free rate used was based on the U.S. Treasury Daily Yield Curve Rate. The stock compensation issued for services during the 6 months ended June 30, 2021, was valued on the date of issuance. The following assumptions were used in calculations of the Black-Scholes option pricing models for warrant-based stock compensation issued in the six months ended June 30, 2021: SCHEDULE OF BLACK-SCHOLES OPTION PRICING MODELS FOR WARRANT-BASED STOCK COMPENSATION 1/5/21 5/18/21 Risk-free interest rate 0.96 % 1.64 % Expected life 10 5 Expected dividends 0 % 0 % Expected volatility 209.98 % 176.37 % ALLM common stock fair value $ 0.124 $ 0.300 Property and Equipment Property and equipment are stated at cost less accumulated depreciation. Depreciation is provided for on a straight-line basis over the useful lives of the assets, generally 5 10 Patent Capitalization If a product is currently under research and development and is not currently approved for market, costs incurred in connection with patent applications should generally be expensed in the income statement because there is uncertainty as to the future economic benefit of the asset. Conversely, if a product is approved for market (as is the case of the end product ethanol), or if future economic benefit is probable, or if an alternative future use is available to the Company, then such patent costs can be capitalized and amortized over the expected life of the patent(s). Since the Company’s primary end product is sugar converting to ethanol, which are in wide use, the Company has determined that it is reasonable to capitalize the patent costs associated with its CTS process, which were $ 152,520 138,016 Research and Development The Company expenses all research and development costs as incurred. For the six months ended June 30, 2021, and June 30, 2020, the amounts charged to research and development expenses were $ 514,860 582,733 Revenue Recognition The Company follows FASB ASC 606 “Revenue Recognition” and recognizes revenue when it is realized or realizable and earned. The Company’s revenues will be derived principally from joint ventures, royalties and eventually corporate owned plants. However, no sales have occurred through those revenue streams to date. The Company considers revenue realized or realizable and earned when all of the following criteria are met: 1. persuasive evidence of an arrangement exists; 2. the product has been shipped or the services have been rendered to the customer; 3. the sales price is fixed or determinable; and, 4. collectability is reasonably assured. Common Stock Purchase Warrants and Other Derivative Financial Instruments The Company classifies as equity any contracts that require physical settlement or net-share settlement or provide it with a choice of net-cash settlement or settlement in the Company’s own shares (physical settlement or net-share settlement) provided that such contracts are indexed to its own stock as defined in ASC 815-40 (“Contracts in Entity’s Own Equity”). The Company classifies as assets or liabilities any contracts that require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside the Company’s control) or give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement). The Company assesses the classification of its common stock purchase warrants and other free-standing derivatives at each reporting date to determine whether a change in classification between assets and liabilities is required. Non-controlling interest in consolidated subsidiaries The accompanying consolidated financial statements include the accounts of Blue Biofuels, Inc. and those subsidiaries that the Company has the ability to control either through voting rights or means other than voting rights. For these subsidiaries, the Company records 100% For subsidiaries that the Company controls but hold less than 100% ownership Investments in non-consolidated affiliates Investments in non-consolidated affiliates are accounted for using the equity method or cost basis depending upon the level of ownership and/or the Company’s ability to exercise significant influence over the operating and financial policies of the investee. When the equity method is used, investments are recorded at original cost and adjusted periodically to recognize the Company’s proportionate share of the investees’ net income or losses after the date of investment. When net losses from an investment are accounted for under the equity method exceed its carrying amount, the investment balance is reduced to zero and additional losses are not provided for. The Company resumes accounting for the investment under the equity method if the entity subsequently reports net income and the Company’s share of that net income exceeds the share of net losses not recognized during the period the equity method was suspended. Investments are written down only when there is clear evidence that a decline in value that is other than temporary has occurred. Impairment of Long-Lived Assets Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset group may not be recoverable. If events or changes in circumstances indicate that the carrying amount of an asset group may not be recoverable, the Company compares the carrying amount of the asset group to future undiscounted net cash flows, excluding interest costs, expected to be generated by the asset group and their ultimate disposition. If the sum of the undiscounted cash flows is less than the carrying value, the impairment to be recognized is measured by the amount by which the carrying amount of the asset group exceeds the fair value of the asset group. Assets to be disposed of are reported at the lower of the carrying amount or fair value, less costs to sell. Income Taxes The Company uses the asset and liability method of accounting for income taxes in accordance with ASC Topic 740, “Income Taxes.” Under this method, income tax expense is recognized for the amount of: (i) taxes payable or refundable for the current year and (ii) deferred tax consequences of temporary differences resulting from matters that have been recognized in an entity’s financial statements or tax returns. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the results of operations in the period that includes the enactment date. A valuation allowance is provided to reduce the deferred tax assets reported if based on the weight of the available positive and negative evidence, it is more likely than not some portion or all of the deferred tax assets will not be realized. ASC Topic 740.10.30 clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. ASC Topic 740.10.40 provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. The Company has no material uncertain tax positions for any of the reporting periods presented. Profit (Loss) per Common Share: Basic profit (loss) per share amounts have been calculated using the weighted-average number of common shares outstanding during each reporting period. Diluted loss per share has been calculated using the weighted-average number of common shares plus the potentially dilutive effect of securities such as outstanding options and warrants. The computation of potential common shares has been performed using the treasury stock method. The warrants and options are antidilutive for all periods presented. When net loss is reported, diluted and basic net loss per share amounts are the same as the impact of potential common shares is antidilutive. Fair Value Measurements The Company adopted the provisions of ASC Topic 820, “Fair Value Measurements and Disclosures”, which defines fair value as used in numerous accounting pronouncements, establishes a framework for measuring fair value and expands disclosure of fair value measurements. The estimated fair value of certain financial instruments, payables to related parties, and accounts payable and accrued expenses are carried at historical cost basis, which approximates their fair values because of the short-term nature of these instruments. ASC 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 describes three levels of inputs that may be used to measure fair value: Level 1 — quoted prices in active markets for identical assets or liabilities Level 2 — quoted prices for similar assets and liabilities in active markets or inputs that are observable Level 3 — inputs that are unobservable (for example cash flow modeling inputs based on assumptions) Recent Accounting Pronouncements From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board or other standard setting bodies that may have an impact on the Company’s accounting and reporting. The Company believes that such recently issued accounting pronouncements and other authoritative guidance for which the effective date is in the future either will not have an impact on its accounting or reporting or that such impact will not be material to its financial position, results of operations, and cash flows when implemented.

ASSETS

ASSETS	6 Months Ended
	Jun. 30, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
ASSETS	NOTE 4 – ASSETS Patents The Company has been granted one patent on its technology, has filed for three others that are pending, and has also applied for international patents. The Company has capitalized the legal and filing fees in the amount of $ 152,520

DEBT

DEBT	6 Months Ended
	Jun. 30, 2021
Debt Disclosure [Abstract]
DEBT	NOTE 5 – DEBT Paycheck Protection Program SBA Loan In May 2020, the Company received a loan in the amount of $ 66,330 1% original maturity date of two years which can be extended to five years Under the terms of the loan, a portion or all of the loan is forgivable to the extent the loan proceeds are used to fund qualifying payroll, rent and utilities during a designated twenty-four-week period. Payments are deferred until the SBA determines the amount to be forgiven. On April 21, 2021, the Company received notice that the entire amount is forgiven. Notes Payable – Chapter 11 Settlement On July 18, 2018, the Company’s former Controller Dennis Lenaburg sued the Company for $ 2,694,577 th 13,650 50,000 1.5 0.30 ten September 18, 2022 Notes Payable – Related Parties In July 2016, the Company issued six (6) short-term notes payable to related parties in conjunction with the Company’s acquisition of the remaining 49% 2,002,126 6% 278,794 176,460 The renegotiated amounts, as per the Plan Confirmation are all to be paid from 50% of the future net profits and discharged to the extent unpaid five years after the Plan effective date of September 18, 2019. These amount are 1) Mark Koch $ 240,990 6% 579,942 6% 1.5 6% On February 28, 2018, the Company entered into a short-term loan with Steven Sadaka, with a principal balance of $ 100,000 May 1, 2018 2,000,000 84,000 7/1/2018 5,000,000 100,000 On May 15, 2018, the Company entered into a short-term loan with Christopher Jemapete, with a principal balance of $ 50,000 May 16, 2019 5% 1,250,000 1,000,000 0.10 5 36,250 24,449 315 50,315 On May 15, 2018, the Company entered into a short-term loan with Pamela Jemapete, with a principal balance of $ 50,000 May 16, 2019 5% 1,250,000 1,000,000 0.10 5 36,250 24,449 315 50,315 Notes Payable – Other In July 2016, the Company issued a short-term note payable to a third party in conjunction with the Company’s acquisition of the remaining 49% 96,570 6% 14,382 8,588 August 4, 2017 five In November 2017, the Company entered into a convertible debenture with Lucas Hoppel, with a principal balance of $ 143,000 May 30, 2018 8% 43,000 35% 500,000 39,500 120% 40,000 40% 100,000 5% In February 2018, the Company entered into a convertible debenture with Lucas Hoppel, with a principal balance of $ 165,000 September 21, 2018 8% 15,000 40% 500,000 14,500 120% 40% 100,000 5% On March 27, 2019, the Company entered into an agreement with Partiz and Company, P.A. such that its debt will be reduced from $ 32,000 20,000 A summary of all debts indicated in the Notes above is as follows: SCHEDULE OF NOTES PAYABLE Notes Payable June 30, 2021 December 31, 2020 Short Term Convertible Debentures Related Party $ - $ 75,000 Long Term Chapter 11 Settlement $ 50,000 $ 50,000 Long Term Paycheck Protection Program SBA loan $ - $ 66,330 Long Term Notes Payable from future revenue — Related Party $ 1,700,630 $ 1,700,630 Long Term Notes Payable from future revenue — Other $ 120,000 $ 120,000 Long Term Note Payable from future profits — Related Party $ 820,932 $ 820,932 Long Term Note Payable from future profits — Other $ 96,570 $ 96,570 Long Term Convertible Debentures — Related Party $ - $ 204,000 TOTAL NOTES $ 2,788,132 $ 3,133,462 Of the $ 2,788,132 2,738,132 2,417,502 2,788,132 5 370,630 200,630 120,000 50,000

STOCKHOLDERS_ EQUITY

STOCKHOLDERS’ EQUITY	6 Months Ended
	Jun. 30, 2021
Equity [Abstract]
STOCKHOLDERS’ EQUITY	NOTE 6 – STOCKHOLDERS’ EQUITY The total number of shares of capital stock, which the Company has authority to issue, is 1,010 0.001 10 0.001 272,311,065 no For the six months ended June 30, 2021, the Company issued an aggregate of 223,000 46,930 For the six months ended June 30, 2021, the Company raised $ 1,950,750 9,303,331 For the six months ended June 30, 2021, 13,455,009 0.10 1,302,817 For the six months ended June 30, 2021, the Company issued an aggregate of 1,166,667 72,090 For the six months ended June 30, 2021, 200,000 177,778 For the six months ended June 30, 2021, 350,000 12,900 For the six months ended June 30, 2021, 13,323,850 For the six months ended June 30, 2021, the Company issued 20,730,000 210,000 For the six months ended June 30, 2021, $ 279,000 7,080,000

SEGMENT INFORMATION

SEGMENT INFORMATION	6 Months Ended
	Jun. 30, 2021
Segment Reporting [Abstract]
SEGMENT INFORMATION	NOTE 7 – SEGMENT INFORMATION The Company operates in one

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	6 Months Ended
	Jun. 30, 2021
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 8 - COMMITMENTS AND CONTINGENCIES Litigation The Company is subject, from time to time, to litigation, claims and suits arising in the ordinary course of business. On June 21, 2018, Power Up Lending Group Ltd., sued both the Company and four of its managers, ex-managers, and directors of the Company in the United States District Court for the Eastern District of New York. The case was dropped against the Company and the claim discharged by the bankruptcy court upon Plan Confirmation on September 18, 2019. Power Up has continued a tort case against the individuals. The D&O insurance has agreed to cover the CEO Ben Slager, CFO Anthony Santelli, as well as ex-Controller Dennis Lenaburg, in this case. Management believes the Complaint is frivolous and has filed a motion to dismiss which is pending before the Court as of the date of this filing. Leases The Company consolidated its premises into one location on November 1, 2019, and currently leases office and laboratory space in Palm Beach Gardens, FL, that is classified as operating lease right-of-use (“ROU”) assets and operating lease liabilities in the Company’s consolidated balance sheet. ROU assets and lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at the commencement date for leases exceeding 12 months. The lease period is for twenty-four (24) months from November 1, 2019, to October 31, 2021 This had been extended for one year until October 31, 2022. 84,100 3% 3,084 ASC 842 was effective for us beginning January 1, 2019. The adoption had a material impact on our consolidated balance sheets, but did not have a material impact on our consolidated income statements. The most significant impact was the recognition of ROU assets and lease liabilities for operating leases. Rent expense for the six months ending June 30, 2021, and 2020, were $ 32,384 31,427 The Company recognized the following related to leases in its Consolidated Balance Sheet: SCHEDULE OF LEASE CONSOLIDATED BALANCE SHEET YEAR ENDED June 30, 2021 December 31, 2020 Right of Use Lease Liabilities Current portion 83,825 80,078 Long-term portion 29,372 72,346 TOTAL 113,197 152,424 As of June 30, 2021, the total future minimum lease payments in respect of leased premises are as follows: SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS YEAR ENDED MINIMUM DUE 2021 40,852 2022 72,345 2023 0 TOTAL $ 113,197

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	6 Months Ended
	Jun. 30, 2021
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 9 – RELATED PARTY TRANSACTIONS Related Party Transactions The Company follows FASB ASC subtopic 850-10, Related Party Disclosures, for the identification of related parties and disclosure of related party transactions. Pursuant to ASC 850-10-20, related parties include: a) affiliates of the Company; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825–10–15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests. 1) Short-term notes payable, convertible notes, and contingent liabilities issued to related parties are described in NOTE 5. 2) A board resolution was passed on February 13, 2020, that pledged the patents and pending patents to secure the back pay claims of Ben Slager, CEO, Anthony Santelli, CFO, and Charles Sills, Director. This was done to ensure the continued involvement of management to build the Company while they continue to receive less than full salaries. The officers and directors for the Company are involved in other business activities and may, in the future, become involved in other business opportunities. If a specific business opportunity becomes available, such persons may face a conflict in selecting between the Company and their other business interest. The Company has not formulated a policy for the resolution of such conflicts.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	6 Months Ended
	Jun. 30, 2021
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 10 – SUBSEQUENT EVENTS The Company has evaluated subsequent events through the date the financial statements were issued. Based on this evaluation, the Company has identified the following subsequent events: From June 30, 2021, to the date of this filing, the Company raised $ 25,000 0.25 100,000 From June 30, 2021, to the date of this filing, 500,000 On July 26, 2021, the Company filed an Amendment to its Articles of Incorporation with the State of Nevada changing the name of the Company to Blue Biofuels, Inc, and increasing the authorized shares to 1,000,000,000 500,000,000

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	6 Months Ended
	Jun. 30, 2021
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying consolidated financial statements of the Company were prepared in accordance with generally accepted accounting principles in the U.S. (“U.S. GAAP”) and include the assets, liabilities, revenues and expenses of the Company’s majority-owned subsidiaries over which the Company exercises control.
Principles of Consolidation	Principles of Consolidation The accompanying consolidated financial statements include the accounts of the Company and its subsidiaries, after elimination of intercompany accounts and transactions. Investments in business entities in which the Company lacks control but has the ability to exercise significant influence over operating and financial policies are accounted for using the equity method. All material intercompany transactions and balances were eliminated in consolidation.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the dates presented and reported amounts of revenues and expenses during the reporting periods presented. Significant estimates inherent in the preparation of the accompanying Consolidated Financial Statements include estimates of impairment assessment of identifiable intangible assets and valuation allowance for deferred tax assets. Estimates are based on past experience and other considerations reasonable under the circumstances. Actual results may differ from these estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents All highly liquid investments with maturities of three months or less at the date of purchase are considered to be cash equivalents.
Stock Compensation	Stock Compensation The Company recognizes the cost of all share-based payments under the relevant authoritative accounting guidance. Share-based payments include any remuneration paid by the Company in shares of the Company’s common stock or financial instruments that grant the recipient the right to acquire shares of the Company’s common stock. For share-based payments to employees, which consist only of awards made under the stock option plan described below, the Company accounts for the payments in accordance with the provisions of ASC Topic 718, “Stock Compensation” (formerly referred to as SFAS No. 123(R)). Share-based payments to consultants, service providers and other non-employees are accounted for in accordance with ASC Topic 718, ASC Topic 505, “Equity Payments to Non-Employees” or other applicable authoritative guidance.
Stock-based Compensation Valuation Methodology	Stock-based Compensation Valuation Methodology Stock-based compensation resulting from the issuance of common stock is calculated by reference to the valuation of the stock on the date of issuance, the expense being recognized as the compensation is earned. Stock-based compensation expenses related to employee options and warrants granted to non-employees are recognized as the stock options and warrants are earned. The fair value of the stock options or warrants granted is estimated at the grant date, using the Black-Scholes option-pricing model, and the expense is recognized on a straight-line basis over the shorter of the period over which services are to be received or the life of the option or warrant. The grant date fair value of employee share options and similar instruments is estimated using the Black-Scholes option-pricing model on the basis of the fair value of the underlying common stock on the measurement date, adjusted for the unique characteristics of those equity instruments, using the assumptions noted in the table below. The fair value of the common stock is determined by the then-prevailing closing market price. Expected volatility was based on the historical volatility of the Company’s closing day market price per share. The expected term of options and warrants was based upon the life of the option, and the risk-free rate used was based on the U.S. Treasury Daily Yield Curve Rate. The stock compensation issued for services during the 6 months ended June 30, 2021, was valued on the date of issuance. The following assumptions were used in calculations of the Black-Scholes option pricing models for warrant-based stock compensation issued in the six months ended June 30, 2021: SCHEDULE OF BLACK-SCHOLES OPTION PRICING MODELS FOR WARRANT-BASED STOCK COMPENSATION 1/5/21 5/18/21 Risk-free interest rate 0.96 % 1.64 % Expected life 10 5 Expected dividends 0 % 0 % Expected volatility 209.98 % 176.37 % ALLM common stock fair value $ 0.124 $ 0.300
Property and Equipment	Property and Equipment Property and equipment are stated at cost less accumulated depreciation. Depreciation is provided for on a straight-line basis over the useful lives of the assets, generally 5 10
Patent Capitalization	Patent Capitalization If a product is currently under research and development and is not currently approved for market, costs incurred in connection with patent applications should generally be expensed in the income statement because there is uncertainty as to the future economic benefit of the asset. Conversely, if a product is approved for market (as is the case of the end product ethanol), or if future economic benefit is probable, or if an alternative future use is available to the Company, then such patent costs can be capitalized and amortized over the expected life of the patent(s). Since the Company’s primary end product is sugar converting to ethanol, which are in wide use, the Company has determined that it is reasonable to capitalize the patent costs associated with its CTS process, which were $ 152,520 138,016
Research and Development	Research and Development The Company expenses all research and development costs as incurred. For the six months ended June 30, 2021, and June 30, 2020, the amounts charged to research and development expenses were $ 514,860 582,733
Revenue Recognition	Revenue Recognition The Company follows FASB ASC 606 “Revenue Recognition” and recognizes revenue when it is realized or realizable and earned. The Company’s revenues will be derived principally from joint ventures, royalties and eventually corporate owned plants. However, no sales have occurred through those revenue streams to date. The Company considers revenue realized or realizable and earned when all of the following criteria are met: 1. persuasive evidence of an arrangement exists; 2. the product has been shipped or the services have been rendered to the customer; 3. the sales price is fixed or determinable; and, 4. collectability is reasonably assured.
Common Stock Purchase Warrants and Other Derivative Financial Instruments	Common Stock Purchase Warrants and Other Derivative Financial Instruments The Company classifies as equity any contracts that require physical settlement or net-share settlement or provide it with a choice of net-cash settlement or settlement in the Company’s own shares (physical settlement or net-share settlement) provided that such contracts are indexed to its own stock as defined in ASC 815-40 (“Contracts in Entity’s Own Equity”). The Company classifies as assets or liabilities any contracts that require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside the Company’s control) or give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement). The Company assesses the classification of its common stock purchase warrants and other free-standing derivatives at each reporting date to determine whether a change in classification between assets and liabilities is required.
Non-controlling interest in consolidated subsidiaries	Non-controlling interest in consolidated subsidiaries The accompanying consolidated financial statements include the accounts of Blue Biofuels, Inc. and those subsidiaries that the Company has the ability to control either through voting rights or means other than voting rights. For these subsidiaries, the Company records 100% For subsidiaries that the Company controls but hold less than 100% ownership
Investments in non-consolidated affiliates	Investments in non-consolidated affiliates Investments in non-consolidated affiliates are accounted for using the equity method or cost basis depending upon the level of ownership and/or the Company’s ability to exercise significant influence over the operating and financial policies of the investee. When the equity method is used, investments are recorded at original cost and adjusted periodically to recognize the Company’s proportionate share of the investees’ net income or losses after the date of investment. When net losses from an investment are accounted for under the equity method exceed its carrying amount, the investment balance is reduced to zero and additional losses are not provided for. The Company resumes accounting for the investment under the equity method if the entity subsequently reports net income and the Company’s share of that net income exceeds the share of net losses not recognized during the period the equity method was suspended. Investments are written down only when there is clear evidence that a decline in value that is other than temporary has occurred.
Impairment of Long-Lived Assets	Impairment of Long-Lived Assets Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset group may not be recoverable. If events or changes in circumstances indicate that the carrying amount of an asset group may not be recoverable, the Company compares the carrying amount of the asset group to future undiscounted net cash flows, excluding interest costs, expected to be generated by the asset group and their ultimate disposition. If the sum of the undiscounted cash flows is less than the carrying value, the impairment to be recognized is measured by the amount by which the carrying amount of the asset group exceeds the fair value of the asset group. Assets to be disposed of are reported at the lower of the carrying amount or fair value, less costs to sell.
Income Taxes	Income Taxes The Company uses the asset and liability method of accounting for income taxes in accordance with ASC Topic 740, “Income Taxes.” Under this method, income tax expense is recognized for the amount of: (i) taxes payable or refundable for the current year and (ii) deferred tax consequences of temporary differences resulting from matters that have been recognized in an entity’s financial statements or tax returns. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the results of operations in the period that includes the enactment date. A valuation allowance is provided to reduce the deferred tax assets reported if based on the weight of the available positive and negative evidence, it is more likely than not some portion or all of the deferred tax assets will not be realized. ASC Topic 740.10.30 clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. ASC Topic 740.10.40 provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. The Company has no material uncertain tax positions for any of the reporting periods presented.
Profit (Loss) per Common Share:	Profit (Loss) per Common Share: Basic profit (loss) per share amounts have been calculated using the weighted-average number of common shares outstanding during each reporting period. Diluted loss per share has been calculated using the weighted-average number of common shares plus the potentially dilutive effect of securities such as outstanding options and warrants. The computation of potential common shares has been performed using the treasury stock method. The warrants and options are antidilutive for all periods presented. When net loss is reported, diluted and basic net loss per share amounts are the same as the impact of potential common shares is antidilutive.
Fair Value Measurements	Fair Value Measurements The Company adopted the provisions of ASC Topic 820, “Fair Value Measurements and Disclosures”, which defines fair value as used in numerous accounting pronouncements, establishes a framework for measuring fair value and expands disclosure of fair value measurements. The estimated fair value of certain financial instruments, payables to related parties, and accounts payable and accrued expenses are carried at historical cost basis, which approximates their fair values because of the short-term nature of these instruments. ASC 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 describes three levels of inputs that may be used to measure fair value: Level 1 — quoted prices in active markets for identical assets or liabilities Level 2 — quoted prices for similar assets and liabilities in active markets or inputs that are observable Level 3 — inputs that are unobservable (for example cash flow modeling inputs based on assumptions)
Recent Accounting Pronouncements	Recent Accounting Pronouncements From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board or other standard setting bodies that may have an impact on the Company’s accounting and reporting. The Company believes that such recently issued accounting pronouncements and other authoritative guidance for which the effective date is in the future either will not have an impact on its accounting or reporting or that such impact will not be material to its financial position, results of operations, and cash flows when implemented.

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	6 Months Ended
	Jun. 30, 2021
Accounting Policies [Abstract]
SCHEDULE OF BLACK-SCHOLES OPTION PRICING MODELS FOR WARRANT-BASED STOCK COMPENSATION	The stock compensation issued for services during the 6 months ended June 30, 2021, was valued on the date of issuance. The following assumptions were used in calculations of the Black-Scholes option pricing models for warrant-based stock compensation issued in the six months ended June 30, 2021: SCHEDULE OF BLACK-SCHOLES OPTION PRICING MODELS FOR WARRANT-BASED STOCK COMPENSATION 1/5/21 5/18/21 Risk-free interest rate 0.96 % 1.64 % Expected life 10 5 Expected dividends 0 % 0 % Expected volatility 209.98 % 176.37 % ALLM common stock fair value $ 0.124 $ 0.300

DEBT (Tables)

DEBT (Tables)	6 Months Ended
	Jun. 30, 2021
Debt Disclosure [Abstract]
SCHEDULE OF NOTES PAYABLE	A summary of all debts indicated in the Notes above is as follows: SCHEDULE OF NOTES PAYABLE Notes Payable June 30, 2021 December 31, 2020 Short Term Convertible Debentures Related Party $ - $ 75,000 Long Term Chapter 11 Settlement $ 50,000 $ 50,000 Long Term Paycheck Protection Program SBA loan $ - $ 66,330 Long Term Notes Payable from future revenue — Related Party $ 1,700,630 $ 1,700,630 Long Term Notes Payable from future revenue — Other $ 120,000 $ 120,000 Long Term Note Payable from future profits — Related Party $ 820,932 $ 820,932 Long Term Note Payable from future profits — Other $ 96,570 $ 96,570 Long Term Convertible Debentures — Related Party $ - $ 204,000 TOTAL NOTES $ 2,788,132 $ 3,133,462

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Tables)	6 Months Ended
	Jun. 30, 2021
Commitments and Contingencies Disclosure [Abstract]
SCHEDULE OF LEASE CONSOLIDATED BALANCE SHEET	The Company recognized the following related to leases in its Consolidated Balance Sheet: SCHEDULE OF LEASE CONSOLIDATED BALANCE SHEET YEAR ENDED June 30, 2021 December 31, 2020 Right of Use Lease Liabilities Current portion 83,825 80,078 Long-term portion 29,372 72,346 TOTAL 113,197 152,424
SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS	As of June 30, 2021, the total future minimum lease payments in respect of leased premises are as follows: SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS YEAR ENDED MINIMUM DUE 2021 40,852 2022 72,345 2023 0 TOTAL $ 113,197

ORGANIZATION (Details Narrative

ORGANIZATION (Details Narrative)	Jun. 30, 2021
CTS 2.0 Technology [Member]
Acquired Indefinite-lived Intangible Assets [Line Items]
Ownership percentage	100.00%

GOING CONCERN (Details Narrativ

GOING CONCERN (Details Narrative) - USD ($)	Jun. 30, 2021	Dec. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Working capital surplus	$ 1,465,475
Accumulated losses	$ 47,781,212	$ 46,682,093
Market price of products	$ 3.06

SCHEDULE OF BLACK-SCHOLES OPTIO

SCHEDULE OF BLACK-SCHOLES OPTION PRICING MODELS FOR WARRANT-BASED STOCK COMPENSATION (Details) - Warrant [Member]	6 Months Ended
	Jun. 30, 2021$ / shares
01/05/2021 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free interest rate	0.96%
Expected life	10 years
Expected dividends	0.00%
Expected volatility	209.98%
ALLM common stock fair value	$ 0.124
05/18/2021 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free interest rate	1.64%
Expected life	5 years
Expected dividends	0.00%
Expected volatility	176.37%
ALLM common stock fair value	$ 0.300

SUMMARY OF SIGNIFICANT ACCOUN_4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2020
Property, Plant and Equipment [Line Items]
Patents	$ 152,520		$ 152,520		$ 138,016
Research and development expenses	$ 249,786	$ 492,117	$ 514,860	$ 582,733
Revenue, percentage	100.00%		100.00%
Ownership percentage, description			For subsidiaries that the Company controls but hold less than 100% ownership
Minimum [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, estimated useful life			5 years
Maximum [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, estimated useful life			10 years

ASSETS (Details Narrative)

ASSETS (Details Narrative)	6 Months Ended
	Jun. 30, 2021USD ($)
Patents [Member]
Finite-Lived Intangible Assets [Line Items]
Legal and filing fees	$ 152,520

SCHEDULE OF NOTES PAYABLE (Deta

SCHEDULE OF NOTES PAYABLE (Details) - USD ($)	Jun. 30, 2021	Dec. 31, 2020
Debt Disclosure [Abstract]
Short Term Convertible Debentures Related Party		$ 75,000
Long Term Chapter 11 Settlement	50,000	50,000
Long Term Paycheck Protection Program SBA loan		66,330
Long Term Notes Payable from future revenue — Related Party	1,700,630	1,700,630
Long Term Notes Payable from future revenue — Other	120,000	120,000
Long Term Note Payable from future profits — Related Party	820,932	820,932
Long Term Note Payable from future profits — Other	96,570	96,570
Long Term Convertible Debentures — Related Party		204,000
TOTAL NOTES	$ 2,788,132	$ 3,133,462

DEBT (Details Narrative)

DEBT (Details Narrative) - USD ($)

Jul. 18, 2018

May 15, 2018

Feb. 28, 2018

May 31, 2020

Nov. 30, 2017

Jul. 31, 2016

Jun. 30, 2021

Dec. 31, 2020

Mar. 27, 2019

Dec. 31, 2018

Jun. 30, 2018

May 31, 2018

Dec. 31, 2017

Short-term Debt [Line Items]

Notes payable

$ 2,788,132

$ 3,133,462

Warrants strike price

$ 0.10

Principal balance of debt

$ 370,630

Debt instrument term

5 years

Notes payable

$ 2,738,132

Long term convertible debentures

2,417,502

Debt amount not discharged or forgiven

2,788,132

Due to related parties

200,630

Due to other

120,000

Note payable to bank

$ 50,000

$ 50,000

Partiz and Company, P.A [Member] | Maximum [Member]

Short-term Debt [Line Items]

Principal balance of debt

$ 32,000

Partiz and Company, P.A [Member] | Minimum [Member]

Short-term Debt [Line Items]

Principal balance of debt

$ 20,000

Short Term Notes Payable [Member]

Short-term Debt [Line Items]

Debt interest rate

6.00%

Principal balance of debt

$ 2,002,126

Accrued interest

$ 278,794

$ 176,460

Plan confirmation description

The renegotiated amounts, as per the Plan Confirmation are all to be paid from 50% of the future net profits and discharged to the extent unpaid five years after the Plan effective date of September 18, 2019.

Debt description

These amount are 1) Mark Koch $240,990 plus 6% interest on any portion not repaid within 12 months of the Company’s first reported quarterly net profit; 2) Animated Family Films $579,942 out of the Company’s net profits plus 6% interest; 3) Steven Dunkle, CTWC, & Wellington Asset Holdings $1.5 million plus 6% interest once there is positive quarterly EBITDA from the first plant of Company, or, at its option, may convert that into an equity investment in the first plant of the Company, measured by a percentage of the total cost to build, subject to a minimum equity interest of 1.25% in said plant.

Short Term Notes Payable [Member] | AMG Energy Group, LLC [Member] | Related Party [Member]

Short-term Debt [Line Items]

Debt interest rate

6.00%

Debt due date

Aug. 4, 2017

Principal balance of debt

$ 96,570

Accrued interest

$ 14,382

$ 8,588

Debt instrument term

5 years

Short Term Notes Payable [Member] | AMG Energy Group [Member]

Short-term Debt [Line Items]

Remaining acquisition percentage

49.00%

Short Term Notes Payable [Member] | AMG Energy Group, LLC [Member] | Related Party [Member]

Short-term Debt [Line Items]

Equity interest rate

49.00%

Short Term Loan [Member] | Steven Sadaka [Member]

Short-term Debt [Line Items]

Debt due date

May 1, 2018

Principal balance of debt

$ 100,000

Debt conversion converted instrument shares issued

2,000,000

Debt conversion amount

$ 84,000

Debt extended maturity date

Jul. 1, 2018

Short Term Loan [Member] | Christopher Jemapete [Member]

Short-term Debt [Line Items]

Debt interest rate

5.00%

Common stock warrants

1,000,000

Warrants strike price

$ 0.10

Warrants term

5 years

Debt due date

May 16, 2019

Principal balance of debt

$ 50,000

Accrued interest

$ 315

Renegotiated amounts

$ 50,315

Debt conversion converted instrument shares issued

1,250,000

Debt conversion amount

$ 36,250

Warrant outstanding value

$ 24,449

Short Term Loan [Member] | Pamela Jemapete [Member]

Short-term Debt [Line Items]

Debt interest rate

5.00%

Common stock warrants

1,000,000

Warrants strike price

$ 0.10

Warrants term

5 years

Debt due date

May 16, 2019

Principal balance of debt

$ 50,000

Accrued interest

$ 315

Renegotiated amounts

$ 50,315

Debt conversion converted instrument shares issued

1,250,000

Debt conversion amount

$ 36,250

Warrant outstanding value

$ 24,449

Short Term Loan [Member] | Animated Family Films [Member]

Short-term Debt [Line Items]

Debt interest rate

6.00%

Renegotiated amounts

$ 579,942

Short Term Loan [Member] | Steven Dunkle, CTWC, & Wellington Asset Holdings [Member]

Short-term Debt [Line Items]

Debt interest rate

6.00%

Renegotiated amounts

$ 1,500,000

Convertible Debt [Member] | Lucas Hoppel [Member]

Short-term Debt [Line Items]

Debt interest rate

8.00%

8.00%

Payments for settlements

$ 100,000

$ 100,000

Debt due date

Sep. 21, 2018

May 30, 2018

Principal balance of debt

$ 165,000

$ 143,000

$ 40,000

Debt conversion converted instrument shares issued

500,000

500,000

Debt conversion amount

$ 14,500

$ 39,500

Debt discount amount

$ 15,000

$ 43,000

Discount rate

40.00%

35.00%

Debt instrument outstanding, percentage

120.00%

120.00%

Outstanding penalty percentage

40.00%

40.00%

Future gross revenue percentage

5.00%

5.00%

Common Stock [Member] | Short Term Loan [Member] | Steven Sadaka [Member]

Short-term Debt [Line Items]

Debt conversion converted instrument shares issued

5,000,000

Debt conversion amount

$ 100,000

Dennis Lenaburg [Member]

Short-term Debt [Line Items]

Payments for settlements

$ 13,650

Claim payable

$ 50,000

Common stock warrants

1,500,000

Warrants strike price

$ 0.30

Warrants term

10 years

Debt due date

Sep. 18, 2022

Dennis Lenaburg [Member] | Stock Warrants [Member]

Short-term Debt [Line Items]

Notes payable

$ 2,694,577

Mark Koch [Member] | Short Term Loan [Member]

Short-term Debt [Line Items]

Debt interest rate

6.00%

Renegotiated amounts

$ 240,990

Payroll Protection Program [Member]

Short-term Debt [Line Items]

Proceeds from loans

$ 66,330

Debt interest rate

1.00%

Debt maturity description

original maturity date of two years which can be extended to five years

STOCKHOLDERS_ EQUITY (Details N

STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020	Dec. 31, 2020
Equity [Abstract]
Number of shares authorized	1,010,000,000
Common stock, par value	$ 0.001		$ 0.001
Preferred stock, shares authorized	10,000,000		10,000,000
Preferred stock, par value	$ 0.001		$ 0.001
Common stock, shares issued	272,311,065		241,721,947
Common stock, shares outstanding	272,311,065		241,721,947
Preferred stock, shares issued	0		0
Preferred stock, shares outstanding	0		0
Number of shares issued for services, shares	223,000
Number of shares issued for services	$ 46,930	$ 35,000
Issuance of common stock and warrants for cash through PPM	$ 1,950,750	$ 547,380
Issuance of common stock and warrants for cash through PPM, shares	9,303,331
Warrants exercised, shares	13,455,009
Warrants excerise price per share	$ 0.10
Warrants exercised	$ 1,302,817
Warrants issued for service	1,166,667
Issuance of warrants for services	$ 72,090
Employee stock options were exercised	200,000
Cashless exercise of stock options, shares	177,778
Employee stock options exercised, shares	350,000
Employee stock options exercised	$ 12,900
Number of warrants expired	13,323,850
Share based payment award options	20,730,000
Vested options issued	210,000	10,300,000
Issuance of common stock in exchange for debt	$ 279,000
Issuance of common stock in exchange for debt, shares	7,080,000

SEGMENT INFORMATION (Details Na

SEGMENT INFORMATION (Details Narrative)	6 Months Ended
	Jun. 30, 2021Integer
Segment Reporting [Abstract]
Number of operating segments	1

SCHEDULE OF LEASE CONSOLIDATED

SCHEDULE OF LEASE CONSOLIDATED BALANCE SHEET (Details) - USD ($)	Jun. 30, 2021	Dec. 31, 2020
Commitments and Contingencies Disclosure [Abstract]
Current portion	$ 83,825	$ 80,078
Long-term portion	29,372	72,346
TOTAL	$ 113,197	$ 152,424

SCHEDULE OF FUTURE MINIMUM LEAS

SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS (Details)	Jun. 30, 2021USD ($)
Commitments and Contingencies Disclosure [Abstract]
2021	$ 40,852
2022	72,345
2023	0
TOTAL	$ 113,197

COMMITMENTS AND CONTINGENCIES_2

COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)	6 Months Ended
	Jun. 30, 2021	Jun. 30, 2020
Lessor, Lease, Description [Line Items]
Annual rent	$ 32,384	$ 31,427
Operating costs	$ 3,084
Office and Laboratory Space [Member]
Lessor, Lease, Description [Line Items]
Lease description	The lease period is for twenty-four (24) months from November 1, 2019, to October 31, 2021
Lease extension period	This had been extended for one year until October 31, 2022.
Annual rent	$ 84,100
Percentage of increase in rent per year	3.00%

SUBSEQUENT EVENTS (Details Narr

SUBSEQUENT EVENTS (Details Narrative) - USD ($)	1 Months Ended	6 Months Ended
	Aug. 13, 2021	Jun. 30, 2021	Jun. 30, 2020	Jul. 26, 2021	Jul. 25, 2021	Dec. 31, 2020
Subsequent Event [Line Items]
Proceeds from issuance of common stock		$ 1,950,750	$ 547,380
Warrant expired		13,323,850
Common stock, shares authorized		1,000,000,000				1,000,000,000
Subsequent Event [Member]
Subsequent Event [Line Items]
Proceeds from issuance of common stock	$ 25,000
Shares issued price per share	$ 0.25
Number of shares issued, shares	100,000
Warrant expired	500,000
Common stock, shares authorized				500,000,000	1,000,000,000